Genetic basis of myocardial infarction: Novel insights from genome-wide association studies

Current Cardiovascular Risk Reports

Volumn 3, Issue 6, 2009, Pages 426-433

  Erdmann, Jeanette ^a   Linsel Nitschke, Patrick ^b   Schunkert, Heribert ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856096229     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-009-0063-2     Document Type: Article

References (55)

1. Samani NJ, Erdmann J, Hall AS, et al.: Genome-wide association analysis of coronary artery disease. N Engl J Med 2007, 357: 443-453.
2. Morgan TM, Krumholz HM, Lifton RP, Spertus JA: Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 2007, 297: 1551-1561.
3. Broeckel U, Hengstenberg C, Mayer B, et al.: A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002, 30: 210-214.
4. Manolio TA, Collins FS: The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med 2009, 60: 443-456.
5. Browning SR: Missing data imputation and haplotype phase inference for genome-wide association studies. Hum Genet 2008, 124: 439-450.
6. Erdmann J, Grosshennig A, Braund PS, et al.: New susceptibility locus for coronary artery disease on chromosome 3q22. 3. Nat Genet 2009, 41: 280-282.
7. Trégouët DA, König IR, Erdmann J, et al.: Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009, 41: 283-285.
8. Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, et al.: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009, 41: 334-341.
9. McPherson R, Pertsemlidis A, Kavaslar N, et al.: A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316: 1488-1491.
10. Helgadottir A, Thorleifsson G, Manolescu A, et al.: A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316: 1491-1493.
11. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, et al.: Genomewide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316: 1331-1336.
12. Zeggini E, Scott LJ, Saxena R, et al.: Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008, 40: 638-645.
13. Scott LJ, Mohlke KL, Bonnycastle LL, et al.: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316: 1341-1345.
14. Broadbent HM, Peden JF, Lorkowski S, et al.: Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008, 17: 806-814.
15. Helgadottir A, Thorleifsson G, Magnusson KP, et al.: The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008, 40: 217-224.
16. Smith JG, Melander O, Lokvist H, et al.: Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: a large-scale genetic association study. Circ Cardiovasc Genet 2009, 2: 159-164.
17. Gschwendtner A, Bevan S, Cole JW, et al.: Sequence variants on chromosome 9p21. 3 confer risk for atherosclerotic stroke. Ann Neurol 2009, 65: 531-539.
18. Schaefer AS, Richter GM, Groessner-Schreiber B, et al.: Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet 2009, 5: e1000378.
19. Shete S, Hosking FJ, Robertson LB, et al.: Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009, 41: 899-904.
20. Wrensch M, Jenkins RB, Chang JS, et al.: Variants in the CDKN2B and RTEL1 regions are associated with highgrade glioma susceptibility. Nat Genet 2009, 41: 905-908.
21. Stacey SN, Sulem P, Masson G, et al.: New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009, 41: 909-914.
22. Bishop DT, Demenais F, Iles MM, et al.: Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009, 41: 920-925.
23. Falchi M, Bataille V, Hayward NK, et al.: Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 2009, 41: 915-919.
24. Sherr CJ: Cell cycle control and cancer. Harvey Lecture 2000, 96: 73-92.
25. Liu Y, Sanoff HK, Cho H, et al.: INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 2009, 4: e5027.
26. Jarinova O, Stewart AF, Roberts R, et al.: Functional analysis of the chromosome 9p21. 3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 2009 Jul 10 (Epub ahead of print).
27. Samani NJ, Raitakari OT, Sipilä K, et al.: Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28: 1679-1683.
28. Coronary Artery Disease Consortium, Samani NJ, Deloukas P, et al.: Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler Thromb Vasc Biol 2009, 29: 774-780.
29. Muendlein A, Geller-Rhomberg S, Saely CH, et al.: Significant impact of chromosomal locus 1p13. 3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis. Atherosclerosis 2009 Mar 19 (Epub ahead of print).
30. Huang H, Pan L, Zhang L, et al.: Association of single nucleotide polymorphism rs599839 on chromosome 1p13. 3 with premature coronary heart disease in a Chinese Han population [Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2008, 25: 686-689.
31. Samani NJ, Braund PS, Erdmann J, et al.: The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol. J Mol Med 2008, 86: 1233-1241.
32. Sandhu MS, Waterworth DM, Debenham SL, et al.: LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008, 371: 483-491.
33. Kathiresan S, Melander O, Guiducci C, et al.: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008, 40: 189-197.
34. Kathiresan S, Willer CJ, Peloso GM, et al.: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009, 41: 56-65.
35. Schadt EE, Molony C, Chudin E, et al.: Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008, 6: e107.
36. Kathiresan S, Melander O, Anevski D, et al.: Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 2008, 358: 1240-1249.
37. Nielsen MS, Jacobsen C, Olivecrona G, et al.: Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 1999, 274: 8832-8836.
38. Nilsson SK, Christensen S, Raarup MK, et al.: Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem 2008, 283: 25920-25927.
39. Linsel-Nitschke P, Heeren J, Aherrahrou Z, et al.: Genetic variation at chromosome 1p13. 3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 2009 Jul 8 (Epub ahead of print).
40. Saito K, Chen M, Bard F, et al.: TANGO1 facilitates cargo loading at endoplasmic reticulum exit sites. Cell 2009, 136: 891-902.
41. Abi-Younes S, Sauty A, Mach F, et al.: The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000, 86: 131-138.
42. Poznansky MC, Olszak IT, Foxall R, et al.: Active movement of T cells away from a chemokine. Nat Med 2000, 6: 543-548.
43. Dudbridge F, Gusnanto A: Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008, 32: 227-234.
44. Hölzel M, Rohrmoser M, Schlee M, et al.: Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J Cell Biol 2005, 170: 367-378.
45. Yoshikawa Y, Satoh T, Tamura T, et al.: The M-Ras-RAGEF-2-Rap1 pathway mediates tumor necrosis factor-alpha dependent regulation of integrin activation in splenocytes. Mol Biol Cell 2007, 18: 2949-2959.
46. Allen PB, Greenfield AT, Svenningsson P, et al.: Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. Proc Natl Acad Sci U S A, 2004, 101: 7187-7192.
47. Holmer SR, Hengstenberg C, Kraft HG, et al.: Assoc iation of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. Circulation 2003, 107: 696-701.
48. Boerwinkle E, Leffert CC, Lin J, et al.: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992, 90: 52-60.
49. Cavdar Koc E, Burkhart W, Blackburn K, et al.: The small subunit of the mammalian mitochondrial ribosome. Identification of the full complement of ribosomal proteins present. J Biol Chem 2001, 276: 19363-19374.
50. Kwon HM, Yamauchi A, Uchida S, et al.: Cloning of the cDNa for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. J Biol Chem 1992, 267: 6297-6301.
51. Abbott GW, Sesti F, Splawski I, et al.: MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97: 175-187.
52. National Human Genome Research Institute: The ENCODE Project: ENCyclopedia Of DNA Elements. Available at http://www. genome. gov/10005107. Accessed July 12, 2009.
53. Courtois G, Morgan JG, Campbell LA, et al.: Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science 1987, 238: 688-692.
54. Reiner AP, Barber MJ, Guan Y, et al.: Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 2008, 82: 1193-1201.
55. Wellcome Trust Case Control Consortium: Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007, 447: 661-678.